biuro@scopefluidics.com +48 22 376 21 14
biuro@scopefluidics.com +48 22 376 21 14
biuro@scopefluidics.com +48 22 376 21 14

RAPORT ESPI 20/2024 | 21-11-2024 | Rozpoczęcie procesu badań klinicznych panelu UNI systemu BACTEROMIC

Previous PostNext Post

Related Posts

16.01.2026

Scope Fluidics Fellowship is back – 2nd edition coming soon!

0
08.01.2026

Scope Fluidics enters into a distribution agreement in the Turkish market

0
01.12.2025

Scope Fluidics Q1–Q3 2025 Results: Secures a stronger cash position and appoints a leading transaction advisor

0